News & Announcements Archive

Auspex Pharmaceuticals Completes Enrollment in Phase 3 Clinical Trial of SD-809 in Chorea Associated With Huntington's Disease (FIRST-HD)

HDBuzz: 2CARE Study of Coenzyme Q for Huntington's Disease Ends

2CARE HD Clinical Trial Stopped Early for Lack of Benefit

Huntington’s Disease Society of America Launches First “HD News” App

Pitt Study Demonstrates How Huntington’s Disease Protein Disrupts a Novel Cellular Pathway to Cause Death of Neurons

World leader in movement disorders Professor Ira Shoulson joins Prana Board

HDSA appoints Director of Marketing & Communications

Pride-HD Study Enrolling Patients Globally to Further Evaluate Pridopidine for the Symptomatic Treatment of Huntington’s Disease

Huntington’s Disease Society of America Announces Winners of the 2014 Donald A. King Summer Research Fellowship

Huntington's Disease Society of America Endorses Enroll-HD

Huntington’s Disease Society of America Announces First-Ever HD Human Biology Project Awards

HDBuzz: 'Induced' Stem Cells Make Exciting Advances

Supreme Court announced its decision regarding PPACA

27th Annual HDSA Convention Videos Available

Law Enforcement Toolkit II Webinar Now Available

Video Postcard from CHDI 2012

ASOs yield promising results in animal models

860 Attendees participated in the 27th Annual HDSA Convention

Researchers Restore Neuron Function to Brains (animal models) using iPSCs

Taryn Reneau to debut Cure, a song dedicated to HD families at the HDSA Convention -- Available on iTunes and CDBaby now

HDSA Launches New Five-Year Strategic Plan

Insights from Prion Disease May Help HD Research

Lundbeck and CHDI collaborate to investigate new potential therapy for HD

Save The Date -- HD Clinical Research Symposium, Saturday, November 10, 2012 in Seattle, Washington

A New Strategy for Treating Neurodegenerative Disorders

SIRT2 inhibition is not a promising therapeutic strategy

Social Security Administration Approves Juvenile HD for Compassionate Allowance Status